ArticleHealth policy and planning2026
Catastrophic costs and impoverishment among tuberculosis-affected households in Nepal: results from a national patient cost survey.
Article in Health policy and planning, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Tuberculosis (TB) poses a significant economic burden on affected households. Despite the provision of free diagnosis and treatment services, patients and their households experience substantial financial hardship. This study aimed to estimate the catastrophic costs faced by TB patients in Nepal and identify associated factors. We conducted the first national cross-sectional survey of 1000 patients enrolled within the National Tuberculosis Program (NTP). The sample consisted of 600 drug-susceptible (DS-TB) and 400 drug-resistant TB (DR-TB) patients. Data were collected through structured interviews using the standardized TB patient cost survey questionnaire. Costs were categorized as direct medical, direct nonmedical, and indirect. Indirect costs were estimated using the human-capital approach. Catastrophic total costs due to TB were defined as total TB-related costs exceeding 20% of annual pre-TB household income. The mean age of participants was 43 years, and 65% were male. Forty-two percent of participants engaged in informal paid work and 70% had not completed secondary education. One-third of the participants reported having some form of social protection, with just 11% possessing health insurance coverage. Overall, 51% of TB-affected households faced catastrophic costs due to TB, with a higher proportion among DR-TB patients (76%) compared with DS-TB patients (51%). The financial burden was primarily driven by direct nonmedical costs (44%) and indirect costs (39%), substantially exceeding direct medical costs (17%). Factors associated with catastrophic total costs included belonging to a poorer wealth quintile, a DR-TB diagnosis, being the primary income earner, and lacking health insurance coverage. TB-related costs pushed 13% of households below the poverty line, increasing to 31% among DR-TB households. Mitigating this burden requires an integrated approach that aligns early diagnostic interventions with comprehensive social protection. Specifically, combining direct cash transfers for wage replacement with in-kind nutritional support is critical to protect high-risk households and reduce nonmedical financial shocks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.